Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-58732
Front Mol Neurosci 2021 Jan 01;14:798261. doi: 10.3389/fnmol.2021.798261.
Show Gene links Show Anatomy links

Activation of SGK1.1 Upregulates the M-current in the Presence of Epilepsy Mutations.

Martin-Batista E , Manville RW , Rivero-Pérez B , Bartolomé-Martín D , Alvarez de la Rosa D , Abbott GW , Giraldez T .


???displayArticle.abstract???
In the central nervous system, the M-current plays a critical role in regulating subthreshold electrical excitability of neurons, determining their firing properties and responsiveness to synaptic input. The M-channel is mainly formed by subunits Kv7.2 and Kv7.3 that co-assemble to form a heterotetrametric channel. Mutations in Kv7.2 and Kv7.3 are associated with hyperexcitability phenotypes including benign familial neonatal epilepsy (BFNE) and neonatal epileptic encephalopathy (NEE). SGK1.1, the neuronal isoform of the serum and glucocorticoids-regulated kinase 1 (SGK1), increases M-current density in neurons, leading to reduced excitability and protection against seizures. Herein, using two-electrode voltage clamp on Xenopus laevis oocytes, we demonstrate that SGK1.1 selectively activates heteromeric Kv7 subunit combinations underlying the M-current. Importantly, activated SGK1.1 increases M-channel activity in the presence of two different epilepsy mutations found in Kv7.2, R207W and A306T. In addition, proximity ligation assays in the N2a cell line allowed us to address the effect of these mutations on Kv7-SGK1.1-Nedd4 molecular associations, a proposed pathway underlying augmentation of M-channel activity by SGK1.1.

???displayArticle.pubmedLink??? 34899186
???displayArticle.link??? Front Mol Neurosci
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: nedd4 sgk1

References [+] :
Armas-Capote, SGK1.1 Reduces Kainic Acid-Induced Seizure Severity and Leads to Rapid Termination of Seizures. 2020, Pubmed